INTRODUCTION
Traditional Chinese Medicine (TCM) with the focus on its herbal constituents is an individual treatment option with growing worldwide popularity [1, 2] , despite still insufficiently documented efficacy [3] and known adverse reactions [4, 5] . In particular, the risk of liver injury in patients under therapy using TCM herbs has appeared as a major problem for many decades [6] . This issue has been known at least since 1983 [7] and is in line with many subsequent case reports and case series [8] [9] [10] [11] [12] [13] [14] [15] . However, there have been attempts to downgrade the hepatotoxic risk of herbal TCM but such proposals were vague and rejected since no proof for this claim was provided [16] . Other problems were recognized as variables, which confounded establishing valid causality [17] [18] [19] . Among these variables were co-medication with other herbal products or synthetic, potentially hepatotoxic Western drugs, low case data quality, incomplete consideration of alternative causes, and questionable quality of herbal TCM products. Indeed, some herbal TCM products are confronted with problems of misidentified herbs, impurities, pesticides, heavy metals, or adulteration by Western drugs to enhance or provide efficacy [20] [21] [22] [23] [24] .
Other challenges included the fact that not all publications used a sophisticated, robust causality assessment method. Nevertheless, Roussel Uclaf Causality Assessment Method (RUCAM) [25] was successfully applied in many cases of suspected liver injury by TCM herbs [25, 26] , including as examples some more recent reports [9, [27] [28] [29] [30] [31] . Further, there was also uncertainty as to whether the observed liver disease could have been present prior to the initiation of the TCM use rather than caused by the herbal TCM therapy itself. Meeting the objections regarding pre-existing liver disease would have required an analytical approach whereby a study protocol is prospectively applied to patients without any liver disease, in whom therapy with herbal TCM is intended and liver tests can be analyzed under such treatment conditions. In patients with new abnormal liver tests under the therapy, causality for the suspected herbal TCM product can easily be assessed using RUCAM. So far, such a systematic prospective, large-scale investigation has not been published on liver-healthy individuals, at least not in the scientific literature available in the English language.
In this report, we present for the first time liver injury data derived from a prospective, hospital-based and large-scale study of 21470 patients, who had no liver disease prior to treatment by herbal TCM. This study focused on the effect of herbal TCM use on the liver integrity of patients with normal liver test results of alanine aminotransferase (ALT), used as a diagnostic biomarker to exclude liver disease. Since this study followed a strict protocol and was conducted under clinical conditions, the risk of confounding variables appeared low and should provide valid data.
MATERIALS AND METHODS

Study design
TCM study cohort:
To assess to what extent herbal TCM treatment leads to liver injury, we designed a protocol for a prospective study in consecutive patients, who were admitted to the Hospital for TCM in Bad Kötzting, Germany. Hospital admission was commonly arranged by patients' general practitioners or medical specialists with the intention of a TCM-based therapy. No restrictions on admission exist for patients residing in Germany, as hospital costs are covered by most German statutory sickness funds. Treatment modalities including indications, choice of specific herbal TCM products, daily dosage, and duration of therapy are based on the recommendations of the Beijing University of Chinese Medicine (BUCM), China [32, 33] . Included in the TCM study cohort were all inpatients with normal ALT values on admission or the following day, who had received treatment with TCM herbs during their hospital stay, and were discharged between January 1, 1994, and December 31, 2015. Initial ALT results were obtained along with a routine blood sampling analysis. The inclusion criteria of normal serum ALT activities on admission ensured a lack of a preexisting liver disease that could later confound the potential diagnosis of liver injury along with herbal TCM treatment. For reasons of transparency, these patients represent the TCM study cohort. ALT was chosen as a specific diagnostic biomarker to clearly exclude or establish a liver disease [25, 34] . Patients with increased ALT values on admission were excluded from the study.
To ensure the good medical care of the patients, six German hospital physicians and eight Chinese physicians who trained at the University of Chinese Medicine in Beijing were in charge of the patients at the 80-bed TCM hospital [35] . Also included in the team was a pharmacist. On admission, hospital physicians provided a complete physical examination for all patients and recorded their past medical history. They also assessed all normal and elevated laboratory values and documented these together with any adverse or medical event during hospitalization in a standardized adverse event record as part of a hospital-based safety and quality assurance program. During the last three days before discharge, the occurrence of liver injury was tested using serum ALT as the appropriate diagnostic tool.
Treatment with TCM was carried out with TCM herbs, given as decoctions from raw materials [36, 37] . Overall TCM treatment may also include acupuncture, Chinese manual therapy, and relaxation therapy, as outlined previously [19, 35] . Western therapies were continued or prescribed if necessary. Details of prescriptions, each single Western drug, all specific TCM treatment modalities, and the duration of treatment were documented systematically in the hospital files. Herbal TCM products were obtained from China [38, 39] . Prior to use in patients, all herbal TCM products delivered to the hospital underwent a comprehensive preclinical drug control program under the guidance of the Center for Drug Research of the Ludwig-Maximilian University Munich and other drug control centers in China. For herbal TCM product quality and safety assessment, established methods were used that included HPLC, colored TLC photographs, and botanical authenticity proof [40] . This approach aimed to reduce the risk of possible falsification of the herbal products and to ensure concentrations of heavy metals, aflatoxins, and microbial contamination were within the allowed limits. Some of the herbal products were thus rejected for human use before being prescribed to any patient, mostly due to a lack of pharmaceutical quality criteria or detection of contaminants outside the regulatory requirements. All herbal TCM products were also analyzed for microbial contamination [41] .
Liver injury study cohort: The liver injury cohort consists of and is limited to those patients of the TCM study cohort who experienced liver injury in connection with treatment with TCM herbs. Liver injury is defined by an elevated serum ALT activity of at least 5 × upper limit normal (ULN) in patients with normal ALT values on admission [25] . Case data of this liver injury cohort were recruited by further scrutinizing the files and adverse event reports supplied by the hospital physicians. Case identification covers age, sex, diagnosis, past medical history, treatment with herbal TCM drugs and conventional drugs, a course of laboratory data, and any adverse or medical event during hospitalization. The case details were recorded and summarized in individual narratives as part of the patients' hospital documents.
For patients identified with newly emerging liver injury, the suspected herbal TCM products were analyzed and closely reviewed. The aim was to highlight TCM medications that might be associated with an increased risk of liver injury. As this safety analysis of herbal TCM drugs was an outcome study within a routine quality assurance program, approval by an ethical review board was not requested. All patients on admission provided informed written consent prior to study enrollment.
Causality assessment using RUCAM
In line with a previous report [19] and the recommendations of the Chinese Society of Hepatology (GSH) [42] , a causality assessment of herb induced liver injury (HILI) for individual cases and herbal TCM products was achieved using RUCAM [25] . This is the most commonly used liver-specific, and validated tool for liver injury cases, and a standard form was used to extract core elements of RUCAM [25] . This assessment requires the initial evaluation of liver injury criteria and its pattern in each suspected case. The core elements of RUCAM include: The time period from the beginning until the cessation of herb intake in relation to disease onset or from the cessation of herb use to the onset of the liver injury; de-challenge characteristics with a course of ALT values after cessation or continuation of the herb use; risk factors such as alcohol abuse, age and pregnancy; co-medication with synthetic drugs or other herbs; search for alternative causes with special care for all hepatitis types; available information on previous herbal hepatotoxicity; and response to unintentional reexposure. RUCAM was performed for the hepatocellular type of injury, and scoring was independently conducted by three hospital physicians (Stefan Hager, Sabine Albrecht, Dieter Melchart). Final RUCAM scores commonly range from -5 to + 14 points and the resulting causality levels are defined as follows: ≤ 0 points, excluded causality; 1-2, unlikely; 3-5, possible; 6-8, probable; and ≥ 9, highly probable [25] .
RESULTS
Flowchart
The inclusion criteria of the TCM study cohort were strict, especially the criterion of normal ALT values on admission and before the initiation of the treatment with herbal TCM. During the study period from 1994 to 2015, overall, 21896 patients were admitted to the hospital, but 426 patients of these had increased ALT values and were not eligible for inclusion in the study, which corresponds to 1.91%. Consequently, 21470 patients fulfilled the inclusion criteria of the TCM study cohort and were treated with herbal TCM ( Figure  1 ). Among these patients of the TCM study cohort, ALT values remained in the normal range in 20600 patients (95.94%) under the TCM treatment. However, treatment led in 733 patients (3.41%) to abnormal ALT values (> 1 × ULN < 2 × ULN), in 111 patients 
TCM study cohort
ALT abnormalities with values in a range from 2 × up to 5 × ULN observed in 111 patients in the TCM study cohort are clearly caused by the herbal TCM treatment ( Figure 1 and Table 1) , with a preference of the ALT range between 2 × and 3 × ULN (Table 1) . These small increases are commonly without clinical relevance and likely due to metabolic adaptation caused by events associated with the metabolism of TCM plant chemicals.
Analysis of the TCM study cohort showed that the age was 52.7 ± 14.0 years (mean ± SD), and females accounted for 71.9% (Table 2 ). All patients in this cohort suffered for about 7.8 years (median) from chronic disorders that led to hospital admission (Table  2) .
Chronic diseases or health conditions prevailed in the patients of the TCM study cohort (Table 2) , whereby the majority experienced psychosomatic diseases as well as chronic pain syndromes. Additional diagnoses were, for example, hypertension and sleep disturbance. Herbal TCM decoctions were provided with four to five prescriptions of about 11 TCM herbs (ranging from a minimum of 6 to a maximum of 19 different herbs) per prescription during the hospital stay. The dosage of each herb was 6-15 g/d. The total 
Liver injury study cohort
The liver injury study cohort consisting of 26 patients with serum ALT ≥ 5 × ULN (Table 1 ) merits further consideration ( Table 2) . Compared with the large TCM study cohort, patients in the liver injury study cohort were older (52.7 ± 14.0 years vs 57.6 ± 10.5 years) and contained a higher percentage of women (71.9% vs 84.6%), whereas the duration of the hospital stay was similar in both cohorts (Table 2 ). There is a long list of indications for herbal TCM treatment in the patients in the liver injury study group, along with individual TCM herbs that were used as medication (Table 3) . For these patients with confirmed liver injury, details are given for maximum ALT values, which range from 140 U/L to 1052 U/L (Table 3) .
TCM herbs were rarely applied as a mono-preparation, but mostly as mixtures consisting of several herbs adding up to 35 different drugs during the patients' four-week stay. The daily dosage was 95 ± 30 g and thus slightly higher than in the TCM study cohort ( Table 2 ). Among the many herbal TCM used by the 26 patients in the liver injury cohort, Bupleuri radix and Scuterllariae radix were the two TCM herbs most frequently implicated in liver injury, with variable RUCAM-based causality gradings. Most of the patients received one to six TCM drugs that were associated with potential liver injury as evidenced from the scientific literature, e.g., one patient (case 8) received six potentially hepatotoxic herbal TCM drugs during their hospital stay (Table 4) .
Narratives
Narratives are essential for case details including treatment conditions and are presented for reasons of transparency and possible re-evaluation by peers or regulatory agencies. The narratives were documented in the hospital case records and are provided for all 26 patients in the liver injury study cohort (Table 5 ). In only one patient (case 8), none of the potential hepatotoxic TCM herbs was prescribed. Half of the patients were also under co-medication with synthetic drugs, initiated prior to admission, and only a few of these drugs are known for their hepatotoxic potential. The RUCAM analysis excluded all co-medicated drugs as the cause of liver injury in the cases under consideration (Table 5) .
Among the liver injury study cohort, 12/26 (46%) of the patients experienced one or more gastrointestinal symptoms such as abdominal pain, diarrhea (6/12), nausea (4/12), vomiting (3/12), and intestinal colicky cramps (3/12) ( Table 2 ). These symptoms are most likely the result of incipient liver injury due to herbal TCM and may be interpreted as a clinical warning signal. Following the discontinuation of herbal TCM treatment, the symptoms rapidly vanished and ALT values normalized in virtually all patients in the liver injury study cohort.
RUCAM-based causality assessment and grading
For all 26 cases in the liver injury study cohort, causality for the used herbal TCM and co-medicated synthetic drugs used was assessed using RUCAM. RUCAM-based causality for TCM herbs was probable in 8/26 patients, possible in 16/26, and excluded in 2/26 cases. All details are presented to facilitate thorough information and reassessment by other groups or regulators (Table 6) .
Assessing causality in the 26 cases is indeed challenging, but RUCAM can handle this condition fairly well. All patients used a mixture of several TCM herbs ( Table 5 ). The exposure conditions of the suspected herbs are identical, especially regarding start of use and discontinuation. Therefore, basic causality gradings should be identical, unless some herbs have a record of known previous liver injury, which gives two extra RUCAM points, as compared to other herbs without such records, which do not allow two extra points. Therefore, differences in causality grading for TCM herbs can be achieved considering the criteria of known hepatotoxicity. In the absence of such criteria, causality must be attributed to all the herbs together that were used, without the possibility of differentiating between the various herbs. Some patients in the liver injury study cohort also used conventional drugs, which were prescribed either before they were included in the study or during hospitalization. RUCAM was also applied to these co-medicated drugs, which may differ regarding their previous hepatotoxicity and their duration of use. However, it is unlikely that drugs may have caused the increases of ALT during the hospitalization since at the time of inclusion in the study, the ALT values were normal.
DISCUSSION
This report provides liver injury data derived from a prospective, hospital-based and large-scale study of 21470 patients, who had no liver disease prior to treatment with TCM herbs for the first time. Clinically relevant liver injury with ALT ≥ 5 × ULN developed in 26 patients (0.12%) ( Figure 1 and Tables 1-5 ). These data suggest that TCM herbs carry a risk of liver injury in line with other reports [9, 27, 28, 43] and concomitantly dismiss contrarian claims that TCM herbs lack hepatotoxic potency [16] . However, the surprisingly low frequency of liver injury caused by herbal TCM in this study ( Figure 1 ) is at a variance with several reports implying that liver injury cases due to these herbs occur at a high frequency [2, 9, 11, 17, 19, 27, 28, 43] . The rarity of liver injury cases found in the present investigation may be explained by the strict study protocol: (1) prospective rather than retrospective study approach; (2) valid exclusion of pre-existing liver disease prior to the start of the therapy with TCM herbs; (3) hospital-based treatment with specifically trained TCM physicians from Germany and China; (4) use of good quality TCM herbal products specifically ascertained by appropriate analyses; (5) therapy with a median of 19.5 d, avoiding prolonged treatment; (6) selective inclusion in the study only of those patients meeting the liver injury criteria ALT ≥ 5 × ULN; and (7) causality assessment using RUCAM and ascertaining ALT dechallenge following discontinuation of the herbal TCM therapy. Such excellent investigational conditions rarely exist under normal field conditions, where patients are evaluated in retrospective studies, and often provide cases of limited data quality [2, 6, 17] , mostly with the lack of a robust causality assessment such as RUCAM [25] . Despite these encouraging data under hospital conditions, herbal TCM treatment outside a hospital setting may be associated with higher liver injury risks, requiring a cautionary statement. Consequently and to err on the side of caution, patients who opt for special therapy with herbal TCM should be informed about the low risk of liver injury and its clinical symptoms.
Supportive evidence of causality for TCM herbs in the injury cases was provided by the rapid decline of ALT to nearly normal values shortly following cessation of herbal use in 24/26 patients (Table 5) , while two patients escaped final ALT analysis (Table 5) . Causality is further supported by the lack of pre-existing liver diseases in the patients in the liver injury study cohort, ruling out that alternative liver diseases could compete with the newly emerging liver injury caused by TCM herbs. Finally, the causality of liver injury for various TCM herbs was established using the updated RUCAM (Table 6) , as published in 2016 [25] . Causality was excluded in two patients, whereas most cases achieved a possible or even a probable causality level. Using both, RUCAM-based causality assessment and positive tests of unintentional re-exposures, valid causality was provided for numerous TCM herbs by other published analyses of liver injury [9, 27, 28, 43] . It appears that patients with acute liver injury due to TCM herbs commonly have a good prognosis and no transition to chronic liver injury, at least under the treatment conditions of a hospital, and is possibly attributed to the exclusion of prolonged treatment as described in the present study (Table 2 ). This favorable outcome is in line with a previous RUCAM-based study, which does not report on severe courses [27] , but is in contrast to a retrospective study [9] and another analysis [28] : Both publications reported severe clinical courses with the risk of acute liver failure, requirement of liver transplant, and of death [9, 28] . In more detail, acute liver failure was reported in 7.8%, a requirement for liver transplant in 0.6%, and a fatality rate in 3.2%, but associated RUCAM-based causality gradings were not published in the study [9] . This was done in another report of 54 patients with an RUCAM-based causality grading of probable for herbal TCM: One patient had used a herbal TCM product for 60 d and required a liver transplantation, while another one died after using TCM herb for 30 d [28] . The difference in outcome between the present study and previous publications [9, 28] cannot validly be explained and is certainly open for discussion, especially regarding the duration of herbal TCM exposure, which was 19.5 d in this study (Table 2) . Of note, in addition to the 21470 patients, who were included in the TCM study cohort due to their normal ALT values, 472 patients corresponding to 2.3% had been admitted to the hospital for TCM treatment with increased ALT values on admission and were therefore not included in the TCM study cohort. If included, these patients may have alternative diagnoses as confounders, as initially increased ALT values may reflect already existing liver disease. Similar to the hospital conditions, alternative causes as confounding variables have been described in suspected cases of All patients showed normal ALT values at admission and experienced liver injury under therapy with herbal TCM. Indication for TCM treatment was based on diagnoses according to ICD classification. Liver injury is defined as ALT > 5 × ULN. TCM herbs with known hepatotoxicity from literature represented in bold [8] [9] [10] . Causality for all bold TCM herbs was assessed using the updated RUCAM [25] . Causality levels are as follows: ≤ 0 points, excluded causality; 1-2, unlikely; 3-5, possible; 6-8, probable; and ≥ 9, highly probable [3] . [44, 45] and HILI [46] including those caused by TCM herbs [9, 46] , and dietary supplements [46] [47] [48] [49] [50] . It is likely that in the real world, some patients seeking therapy with TCM herbs have a pre-existing, initially not recognized liver disease [9] . Uncertainty exists as to whether pre-existing liver disease is a risk factor for liver injury by TCM herbs, in analogy to some chronic liver diseases such as non-alcoholic fatty liver disease or alcoholic liver disease, which are risk factors of druginduced liver injury (DILI) by some special drugs [51, 52] . Our study clearly differentiated liver injury with ALT values of ≥ 5 × ULN from ALT abnormalities with ALT values of < 5 × ULN (Table 1 ). Those are considered as an adaptive phenomenon due to the metabolism of the chemicals provided from the herbs to the liver. These adaptive abnormalities are clinically not relevant. The present data do not allow the general clinical recommendations to analyze ALT before therapy with TCM herbs is considered, as liver injury is unpredictable. ALT assessment may be helpful in legal situations to prevent later patient claims.
The rarity of hepatotoxic reactions together with normal dosages of herbal TCM used in this study imply idiosyncrasy as a cause rather than an intrinsic mechanism, which is dose-dependent and can be elucidated by experimental studies. However, pathogenetic steps leading to the dose-independent idiosyncratic liver injury are largely unknown due to lack of appropriate animal models [17] . In analogy with other herbs, TCM herbs including those incriminated as 
Alternative cause highly probable Total score for causality: ≤ 0/excluded; 1-2/unlikely; 3-5/possible; 6-8/probable; ≥ 9/highly probable. Considered were the items for the hepatocellular type of liver injury and the data of 26 patients with normal ALT values at hospital admission, who experienced elevated ALT levels > 5 × ULN after use of herbal TCM. In the above section 4 (part 1 of the tabula) of concomitant drug(s), the following TCM herbs and drugs were considered. In the section 5 (search for alternative causes in part 2 of the tabula), the symbol of (n) denotes that the obtained result was negative, whereas (Ø) indicates that assessment was not performed. causes of liver injury in the present study (Tables 3 and  5) contain dozens of known chemicals as ingredients but their specific hepatotoxic potency is difficult to assess and remains largely unknown [28] . Another problem of most TCM therapy regimens is the multiplicity of herbs included as ingredients in herbal mixtures [19, 28] , such as up to 35 in the present study (Table 5) . Multiple plant chemicals of many herbs may lead to an increased risk of liver injury, which were described at least for DILI if several drugs were co-administered [53] , and for herb-herb interactions or herb-drug interactions, if concomitantly used with Western drugs [54] . Used as co-medication to Western antipsychotic drugs such as quetiapine, clozapine, and olanzapine, in the case of Bupleuri radix it is known that this is associated with nearly 60% of the risk of adverse outcomes [4, 12, 55] . Other potential risk factors for liver injury by TCM herbs may include higher dosages and lipophilicity of chemicals and known conditions from DILI cases [56] . Publications on the quality problems of some herbal TCM products [20] [21] [22] [23] [24] called for providing excellent quality for our patients as high priority, which is a strength of this study and avoids discussions around product quality as causative for the observed liver injury.
In the present study, Bupleuri radix and Scutellariae radix are the two TCM herbs most implicated in liver injury (Tables 3-5 ). However, both herbs turned out to be the most frequently prescribed drugs in the TCM hospital in Bad Kötzting in general [57] . Even though liver injury from Polygonum multiflorum has increasingly been reported in recent years [9] [10] [11] , but convincing evidence for causality is limited in the present analysis (Tables 3-5) . Previous regulatory discussions focused on herbal products containing unsaturated pyrrolizidine alkaloids (PAs), and in 2012, EMA stated that herbal medicinal products containing herbal preparations with toxic, unsaturated PAs (even in very low amounts) should not be used orally [58] . Used in high amounts for a prolonged period, PAs can cause HSOS (hepatic sinusoidal obstruction syndrome) [19] . TCM herbs also include Jue Ming Zi (Cassia), but only its leaves and fruits contain PAs and may cause HSOS [19, 58] . Cassiae semen lacks PAs that has been used by two patients, who as expected had no signs of HSOS (Table 5 ).
The use of herbal TCM is widely considered less risky as compared with synthetic drugs, although data on direct comparisons are not available in support of this view. Populations using herbal TCM, drugs, either alone, or combined experience more DILI than HILI, possibly due to a higher use of drugs [27] . Valid data of incidence and prevalence of HILI caused by TCM herbs are lacking [19] , and respective data cannot be derived from the present study with a low frequency of liver injury of 0.12% among all 21470 patients treated with herbal TCM. Valid data were published for drugs, showing that idiosyncratic DILI is a rare event, in a population-based French study with an annual estimated incidence of 13.9 ± 2.4 cases per 100000 inhabitants [53] . A good overview of suspicious TCM herbs is provided in several reports [2, [13] [14] [15] 34] , which were also used for comparison in our own survey (Table 5) . Nevertheless, the list of suspected TCM herbs remains tentative (Tables 3-5) .
Limitations of our study: The focus of our investigation was on ALT levels > 5 × ULN, considering thereby real HILI cases. Cases with ALT elevations between 2 and 5 × ULN are per definition not real but milder HILI due to treatment with TCM herbs, not requiring additional causality proof using RUCAM. As all patients with real HILI had a good outcome with ALT normalization during the relatively short followup periods, this favorable outcome can be expected also for patients with milder HILI. A single normal pre-treatment ALT value likely excludes pre-existing liver disease, though little uncertainty remains, which would decrease rather than increase the overall frequency of HILI by TCM. By study protocol, patients with increased ALT values were explicitly not included, although it would have been of interest how TCM treatment influences increased pre-treatment ALT values.
In this report, we present liver injury data for the first time derived from a prospective, hospital-based and large-scale study of 21470 patients, who received treatment with TCM herbs and had no liver disease before. ALT was used as a diagnostic biomarker to exclude liver disease prior to therapy initiation and to assess liver integrity during and after the therapy. This study of 21470 patients revealed that herbal TCM products cause rare liver injury in 26 patients corresponding to 0.12%. Liver injury rapidly improved in most patients following cessation of the therapy, also substantiating causality for the suspected TCM herbs. Under the present study conditions, a transition of acute liver injury to a chronic course was not observed. As these encouraging results are based on strict protocol in a hospital setting, it remains to be established whether these data can be transferred to normal field conditions. Indeed, in the real world confounding variables prevail, such as pre-existing chronic liver diseases, complex therapy conditions of co-medication with Western drugs, and possible problems of herbal TCM product quality regarding misidentification of herbs, impurities of heavy metals, pesticides and other toxins, and adulteration by Western drugs to enhance efficacy. To be on the side of caution and for risk minimizing physicians are well advised to inform patients about the low risk and symptoms of liver injury associated with the use of TCM herbs, if patients decide on this special therapy option.
COMMENTS
Background
Herbal Traditional Chinese Medicines (TCMs) are worldwide in common use, which is well documented in the literature. They are highly appreciated, as they are of natural origin, and mainly based the belief of their efficiency and lack of adverse events, and their preference as valuable alternatives over a conventional treatment with synthetic drugs. However, some criticism emerged regarding the issue of efficiency, and adverse reactions ranging from clinically not relevant events to more severe ones including suspected liver injury.
Research frontiers
In a prospective, hospital-based study, patients with normal values of alanine aminotransferase (ALT) as a diagnostic marker for ruling out pre-existing liver disease were enrolled and reassessed on discharge by routine laboratory within a safety program carried out at the First German Hospital of TCM from 1994 to 2015. Liver injury was detected in 26/21470, patients (0.12%) with normal liver tests prior to treatment initiation. In most of the liver injury cases, the Roussel Uclaf Causality Assessment Method (RUCAM)-based causality for herbal TCM was graded as "possible".
Innovations and breakthroughs
In this report, the authors present for the first time liver injury data derived from a prospective, hospital based and large-scale study of 21470 patients, who received treatment with TCM herbs and had no liver disease before.
Applications
The findings in this study may help to bring more objectification into discussion about TCM herbs and their risks of liver injury. As long as the therapeutic efficacy of TCM herbs is poorly documented in the scientific literature, even low risk of liver injury by TCM herbs has to be communicated to all potential consumers and to the academic public.
Terminology
Liver injury was defined ALT ≥ 5 × ULN = upper limit of normal as clinically relevant.
Peer-review
This is an interesting and well-written study.
